MedTrace Logo

Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974

NCT07488819 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-06-11

No results posted yet for this study

Summary

Imaging PDE4B in people with psychiatric disorders with PET and the radiotracer \[18F\]PF974

Conditions

  • Post-Traumatic Stress Disorder, PTSD
  • Alcohol Use Disorder (AUD)

Interventions

DRUG

PF974

PF974 Radiotracer.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Kelly Cosgrove, PhD · Yale University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-07
Primary Completion
2031-03-01
Completion
2032-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07488819 on ClinicalTrials.gov